Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4.
Zeng J, Fang Y, Zhang Z, Lv Z, Wang X, Huang Q, Tian Z, Li J, Xu W, Zhu W, Yu J, Liu T, Qian Q.
Zeng J, et al. Among authors: wang x.
Oncogene. 2024 May 28. doi: 10.1038/s41388-024-03066-5. Online ahead of print.
Oncogene. 2024.
PMID: 38806619